|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM164324038 |
003 |
DE-627 |
005 |
20231223102241.0 |
007 |
tu |
008 |
231223s2006 xx ||||| 00| ||eng c |
028 |
5 |
2 |
|a pubmed24n0548.xml
|
035 |
|
|
|a (DE-627)NLM164324038
|
035 |
|
|
|a (NLM)16861041
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Cunningham Rundles, Charlotte
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a New developments in primary immunodeficiencies
|b Report on the 2006 CIS Primary Immunodeficiency Diseases Consortium Conference, June 1, 2006
|
264 |
|
1 |
|c 2006
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Date Completed 05.01.2007
|
500 |
|
|
|a Date Revised 01.12.2018
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
650 |
|
4 |
|a Congress
|
650 |
|
4 |
|a Letter
|
700 |
1 |
|
|a Fleisher, Thomas
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Markert, Mary Louise
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Orange, Jordan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ochs, Hans
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Sullivan, Kathleen
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 121(2006), 3 vom: 01. Dez., Seite 369-71
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:121
|g year:2006
|g number:3
|g day:01
|g month:12
|g pages:369-71
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 121
|j 2006
|e 3
|b 01
|c 12
|h 369-71
|